Subscribe to RSS - sleep apnea

sleep apnea

OSA affects more Europeans than previously thought, ResMed says

 - 
09/19/2018

PARIS – Approximately 175 million Europeans have obstructive sleep apnea, including 90 million with moderate to severe OSA, according to an abstract presented by ResMed at the European Respiratory Society’s annual ERS Congress.

ASAA details apnea’s impact

 - 
09/06/2018

WASHINGTON – The American Sleep Apnea Association released a report on Sept. 5 that details the impact of sleep apnea on patients and families.

ResMed, Verily join forces on sleep apnea

 - 
07/11/2018

SAN DIEGO – ResMed has partnered with Verily on a new joint venture to study the health and financial impacts of undiagnosed and untreated sleep apnea, the companies announced today.

Growth was off for F&P Healthcare’s masks

 - 
05/31/2018

IRVINE, Calif. – Fisher & Paykel Healthcare reported operating revenue grew 10% to a record NZD 980.8 million, or 9% in constant currency terms, for fiscal year 2018.

Sleep market embraces tech

 - 
05/29/2018

Seeking encouraging news among the chronic beleaguerment in the HME market can be a challenge, but one area where providers may find hope is with sleep therapy.

Data-driven therapy 'way of future'

 - 
05/29/2018

Treating obstructive sleep apnea makes patients feel better, reduces co-morbidities, and saves money—a win all around. That doesn’t make it any easier for patients to get used to their device, says Michael Cantor, chief medical officer for CareCentrix.

Upcoming meeting matches sleep patients with regulators

 - 
05/18/2018

WASHINGTON – For several years, Congress and patient advocates have demanded that patients have a greater voice in the U.S. Food and Drug Administration’s product review process.

ResMed rides connected health wave overseas

 - 
04/27/2018

SAN DIEGO – ResMed got a nice boost from Europe and Asia in the third quarter of fiscal year 2018, as growth in the U.S. slowed slightly.

Sleep patients have their say

 - 
04/26/2018

WASHINGTON – Sleep apnea patients and their family members will share perspectives on living with the condition with Food and Drug Administration regulators, drug and medical device developers, and researchers, according to a release from the American Sleep Apnea Associat

ATS, ResMed launch fellowship

 - 
04/24/2018

NEW YORK – The ATS Foundation and ResMed have partnered on a new fellowship in sleep-disordered breathing and PAP therapy. The ATS Foundation/ResMed Research Fellowship is made possible through a $100,000 contribution from ResMed.

Pages